StemMed Competitors and Similar CompaniesClear all

StemMed's competitors and similar companies include Moleculin Biotech and Elevation Oncology.

	StemMed StemMed is a pharmaceutical development and testing company that provides pre-clinical drug testing services using a panel of patient-derived xenograft (PDX) models of breast and pancreatic cancers.	Moleculin Biotech Moleculin Biotech is a pharmaceutical company focused on the development of anti-cancer drug candidates.	Elevation Oncology Elevation Oncology is a biopharmaceutical company focused on the development of precision medicines for patients with genomically defined cancers.
Founding Date	Founding Date 2009	Founding Date 2006	Founding Date 2019
Type	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Houston, US HQ	Locations Houston, US HQ	Locations New York, US HQ
Employees	Employees 2	Employees 176% decrease	Employees 8
Valuation ($)	Valuation ($) N/A	Valuation ($) 7.5 m	Valuation ($) 35.1 m
Financial
Net income	Net income N/A	Net income ($33.6m) (FY, 2025)	Net income ($44.5m) (FY, 2024)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 491k	Total funding raised $ 97.5m